SNY up2% 02-23-2012 Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis http://www.biomedreports.com/2012022389944/genzyme-announces-ema-accepts-oral-teriflunomide-marketing-application-for-treatment-of-multiple-sclerosis.html stockcharts.com/c-sc/sc?s=sny&p=d&yr=0&mn=3&dy=0&id=p81080569603